BAMCO INC /NY/ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$29,895,000
-49.9%
414,122
-2.7%
0.11%
-53.7%
Q3 2019$59,715,000
-23.3%
425,656
+0.2%
0.25%
-21.2%
Q2 2019$77,807,000
+13.6%
424,964
-1.3%
0.31%
+7.6%
Q1 2019$68,482,000
+109.5%
430,570
+26.2%
0.29%
+75.8%
Q4 2018$32,694,000
-28.0%
341,309
+6.1%
0.16%
-12.2%
Q3 2018$45,425,000
+7.7%
321,596
+19.3%
0.19%
+2.2%
Q2 2018$42,192,000
+42.9%
269,543
+47.1%
0.18%
+35.3%
Q1 2018$29,518,000
+103.4%
183,263
+108.0%
0.14%
+103.0%
Q4 2017$14,515,000
+149.3%
88,123
-5.7%
0.07%
+139.3%
Q3 2017$5,822,000
-10.9%
93,458
+13.9%
0.03%
-15.2%
Q2 2017$6,532,000
+18.6%
82,024
+5.8%
0.03%
+13.8%
Q1 2017$5,509,000
+22.2%
77,510
-12.2%
0.03%
+16.0%
Q4 2016$4,510,000
+33.6%
88,320
+20.4%
0.02%
+38.9%
Q3 2016$3,377,000
+139.2%
73,331
+56.4%
0.02%
+125.0%
Q2 2016$1,412,000
+588.8%
46,876
+632.0%
0.01%
+700.0%
Q1 2016$205,000
-45.0%
6,4040.0%0.00%
-50.0%
Q4 2015$373,000
-34.7%
6,404
-52.6%
0.00%
-33.3%
Q3 2015$571,000
+4.4%
13,500
+80.0%
0.00%
+50.0%
Q2 2015$547,0007,5000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders